Daily Text Message Symptom Checks for People With Multiple Myeloma or AL Amyloidosis
Looks at daily text message symptom checks in adults treated for these conditions.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 25 Aug 2026
- Expected to end
- 25 Aug 2028
- Type of study
- Observational
- Treatments tested
- Non-Interventional Study
- Record updated
- 30 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with multiple myeloma or AL amyloidosis who are about to start a new treatment. They will get daily text messages about their symptoms.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Multiple myeloma (MM) or AL amyloidosis (AL), diagnosed by IMWG diagnostic criteria
- Earlier treatment
- Planned to start a new treatment within 14 days (+/-7 days)
Main reasons for not taking part
- Not able to give informed consent
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age >= 18 years
- Diagnosis of MM or AL based on IMWG diagnostic criteria
- Planned to start a new treatment within 14 days (+/-7 days)
- Able to provide written informed consent
Who cannot take part
- Not able to give informed consent
Where in United States
- Mayo Clinic in RochesterRochester, United StatesContact: Sarah AugTaking people
About the trial
What the trial wants to find out
This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.
The group in the trial
- Observational
Patients are enrolled in the Quality of life text message system and receive SMS text messages and complete questionnaires daily for 3 months on study.
Treatment: Non-Interventional Study
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
- Plain-language title
- Daily Text Message Symptom Checks for People With Multiple Myeloma or AL AmyloidosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 30 September 2026